MMP2 and prostate carcinoma: Annexin A5, one of the exosome proteins in prostate cancer tissues, activates AKT signaling to stimulate the epithelial–mesenchymal transition (EMT) and upregulate matrix metalloproteinase-2 (MMP2) and MMP9 expression [5].